LEERINK CENTER FOR PHARMACOECONOMICS Trademark

Trademark Overview


On Wednesday, November 27, 2024, a trademark application was filed for LEERINK CENTER FOR PHARMACOECONOMICS with the United States Patent and Trademark Office. The USPTO has given the LEERINK CENTER FOR PHARMACOECONOMICS trademark a serial number of 98876472. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, September 11, 2025. This trademark is owned by Leerink Intermediate Holdings LLC. The LEERINK CENTER FOR PHARMACOECONOMICS trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Insurance & Financial Services, and Education & Entertainment Services categories with the following description:

Providing a website featuring online non-downloadable content in the nature of instructional videos, related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance

Downloadable reports, electronic newsletters and printable educational materials in the field of financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Downloadable computer software for organizing and sharing commentary, resources, and evaluations related to business information, financial information, and consulting for the same; Downloadable computer software and downloadable mobile applications for use in investment banking management, accessing and conducting banking and financial business, and obtaining information, research, analysis, and advice in the fields of investments, banking, and financial services

Financial services, namely consulting and advising related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Financial consulting; Investment advisory and consulting services; Financial services, namely, investment advice, investment management, investment consultation; Information, advisory, consultancy and financial research services relating to finance and investments

Business consulting; Business advisory; Acquisition and merger consultation; Providing trade information; Compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; Business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business value of medical and pharmaceutical innovation and technology
leerink center for pharmacoeconomics

General Information


Serial Number98876472
Word MarkLEERINK CENTER FOR PHARMACOECONOMICS
Filing DateWednesday, November 27, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, September 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 30, 2025

Trademark Statements


Goods and ServicesProviding a website featuring online non-downloadable content in the nature of instructional videos, related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance
Description of MarkThe mark consists of the word "LEERINK" to the left of a design element consisting of a vertical rectangular block to the left of a smaller vertical rectangular block above a horizontal rectangular block, with all of the foregoing above the words "CENTER FOR PHARMACOECONOMICS"
Goods and ServicesDownloadable reports, electronic newsletters and printable educational materials in the field of financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Downloadable computer software for organizing and sharing commentary, resources, and evaluations related to business information, financial information, and consulting for the same; Downloadable computer software and downloadable mobile applications for use in investment banking management, accessing and conducting banking and financial business, and obtaining information, research, analysis, and advice in the fields of investments, banking, and financial services
Goods and ServicesFinancial services, namely consulting and advising related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Financial consulting; Investment advisory and consulting services; Financial services, namely, investment advice, investment management, investment consultation; Information, advisory, consultancy and financial research services relating to finance and investments
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness consulting; Business advisory; Acquisition and merger consultation; Providing trade information; Compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; Business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business value of medical and pharmaceutical innovation and technology
NOT AVAILABLECENTER FOR PHARMACOECONOMICS

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, November 27, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLeerink Intermediate Holdings LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02109

Trademark Events


Event DateEvent Description
Wednesday, November 27, 2024NEW APPLICATION ENTERED
Thursday, May 15, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 20, 2025ASSIGNED TO EXAMINER
Wednesday, May 28, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 28, 2025NON-FINAL ACTION E-MAILED
Monday, August 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 24, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED